Hussman Strategic Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $417 Million
- Q1 2024
A detailed history of Hussman Strategic Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 21,000 shares of HRMY stock, worth $648,690. This represents 0.17% of its overall portfolio holdings.
Number of Shares
21,000
Previous 21,000
-0.0%
Holding current value
$648,690
Previous $678,000
3.98%
% of portfolio
0.17%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$347 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$183 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$112 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$80.5 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$77.1 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.83B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...